Brellium

Brellium successfully expands beyond its initial behavioral health focus into new specialties like hospice and weight loss, leveraging its 60+ EMR integrations and financial guarantee to capture significant market share from manual processes and less agile competitors. Revenue scales rapidly to over $150M ARR by 2028, justifying a $1B+ valuation at a 6-7x revenue multiple, driven by strong customer retention and continued product innovation against incumbent threats.

Brellium maintains its strong position in niche behavioral health markets, growing steadily but facing increasing pressure from EHR incumbents like Epic and Oracle Cerner, who integrate similar AI compliance features. The company achieves $75M ARR by 2028, leading to an acquisition at a modest 5x revenue multiple, valuing the company at $375M, which provides a moderate return for common shareholders.

Dominant EHR vendors like Epic and Oracle Cerner, along with new offerings like Microsoft Dragon Copilot, aggressively integrate native AI compliance solutions directly into their platforms, commoditizing Brellium's core offering. Customer acquisition stalls, and existing clients face pressure to consolidate vendors. Growth slows significantly, leading to a down round or a distressed acquisition at a valuation of $62.5M or less, wiping out most common stock value due to liquidation preferences.